MedPath

Granulocyte colony stimulating factor administration in assisted reproductive programs.

Not Applicable
Conditions
Female infertility.
Female infertility, unspecified
Registration Number
IRCT201108116420N8
Lead Sponsor
Yazd reaserch and clinical center for infertility
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

all patients with thin endometrium in spite of receiving standard treatment in 12-13th day of frozen-thawed embryo transfer cycle. Exclusion criteria: all patient with history of hypersensitivity to G-CSF; endocrine or systemic diseases; endometriosis; repeated implantation failure; repeated abortion; patients with any cogenital uterine anomaly or aquired uterine diseases with or without operation; age below 20 years; age above 40 years.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrial thickness. Timepoint: 13th and 17th day of menstural cycle. Method of measurement: vaginal sonography.
Secondary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: serum Bhcg.;Clinical pregnancy. Timepoint: 28 days after embryo transfer. Method of measurement: vaginal sonography.
© Copyright 2025. All Rights Reserved by MedPath